Financial reports
10-Q
2023 Q1
Quarterly report
9 Feb 23
10-K/A
2022 FY
Annual report (amended)
27 Jan 23
10-K
2022 FY
Annual report
22 Nov 22
10-Q
2022 Q3
Quarterly report
5 Aug 22
10-Q
2022 Q2
Quarterly report
6 May 22
10-Q
2022 Q1
Quarterly report
4 Feb 22
10-K
2021 FY
Annual report
23 Nov 21
10-Q
2021 Q3
Quarterly report
6 Aug 21
10-Q
2021 Q2
Quarterly report
7 May 21
10-Q
2021 Q1
Quarterly report
5 Feb 21
Current reports
8-K
SD Biosensor and SJL Partners Complete Transaction to Acquire Meridian Bioscience
1 Feb 23
8-K
Meridian Bioscience Announces Anticipated Closing Date of the Pending Merger
12 Dec 22
8-K
Meridian Bioscience Reports Fourth Quarter and Full Year Fiscal 2022 Operating Results
22 Nov 22
8-K
Submission of Matters to a Vote of Security Holders
11 Oct 22
8-K
Other Events
30 Sep 22
8-K
Meridian Bioscience Reports Third Quarter Fiscal 2022 Operating Results
5 Aug 22
8-K
Meridian Bioscience Receives Re-Authorization from FDA for its Revogene® SARS-CoV-2 Molecular Assay
29 Jul 22
8-K
Meridian Bioscience, Inc. Enters into Agreement to Be Acquired by SD Biosensor and SJL Partners in $1.53 Billion All-Cash Transaction
7 Jul 22
8-K
Meridian Bioscience Announces Preliminary Results for Fiscal 2022 Third Quarter
7 Jul 22
8-K
Meridian Bioscience Reports Record Second Quarter Fiscal 2022 Operating Results
6 May 22
Registration and prospectus
15-12G
Securities registration termination
13 Feb 23
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Feb 23
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Feb 23
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Feb 23
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Feb 23
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Feb 23
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Feb 23
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Feb 23
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Feb 23
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Feb 23
Proxies
DEFA14A
Additional proxy soliciting materials
30 Sep 22
DEFM14A
Proxy related to merger
8 Sep 22
PREM14A
Preliminary proxy related to merger
25 Aug 22
DEFA14A
Additional proxy soliciting materials
8 Jul 22
DEFA14A
Additional proxy soliciting materials
7 Jul 22
DEFA14A
Additional proxy soliciting materials
7 Jul 22
DEFA14A
Additional proxy soliciting materials
7 Jul 22
DEFA14A
Additional proxy soliciting materials
7 Jul 22
DEFA14A
Additional proxy soliciting materials
15 Dec 21
DEF 14A
Definitive proxy
15 Dec 21
Other
EFFECT
Notice of effectiveness
6 Feb 23
EFFECT
Notice of effectiveness
6 Feb 23
EFFECT
Notice of effectiveness
6 Feb 23
EFFECT
Notice of effectiveness
6 Feb 23
EFFECT
Notice of effectiveness
6 Feb 23
SD
Conflict minerals disclosure
27 May 22
SD
Conflict minerals disclosure
27 May 21
EFFECT
Notice of effectiveness
28 Dec 20
CORRESP
Correspondence with SEC
18 Dec 20
UPLOAD
Letter from SEC
25 Nov 20
Ownership
SC 13G/A
VANGUARD GROUP INC
9 Feb 23
SC 13D/A
Magnetar Financial LLC
3 Feb 23
4
Felicia Williams
31 Jan 23
4
Catherine Sazdanoff
31 Jan 23
4
John McCune Jr. Rice
31 Jan 23
4
John McIlwraith
31 Jan 23
4
Dwight E Ellingwood
31 Jan 23
4
Anthony P Bihl III
31 Jan 23
4
James M. Anderson
31 Jan 23
4
John P. Kenny
31 Jan 23